SavedAdd your journal

Journals / Anadolu Tıp Dergisi / 2000 / Cilt: 2 - Sayı: 2

The relation between P53 and proliferating cell nuclear antigen (PCNA) expression with histological grade in the prostate adenocarcinoma

Prostat adenokarsinomunda P53 ve proliferating cell nuclear antigen (PCNA) ekspresyonu ile histolojik grade arasındaki ilişki

Hayrettin ŞAHİN
Nihal KILINÇ
Fahri YILMAZ
Adem ARSLAN
Ali Kemal UZUNLAR
Mehmet YALDIZ
Pages
101–106
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a significant correlation between grade and Gleason score with p53 and PCNA (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Forty cases with prostate carcinoma that are diagnosed at Pathology Department of Dicle University between 1996 and 1998 were included in this study.
📊
Key Findings & Data:Slides of the cases were stained with p53 and PCNA, and the correlation between grade and Gleason score for each patient was investigated.
💡
Conclusion & Impact:There was a significant correlation between grade and Gleason score with p53 and PCNA (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Forty cases with prostate carcinoma that are diagnosed at Pathology Department of Dicle University between 1996 and 1998 were included in this study. Slides of the cases were stained with p53 and PCNA, and the correlation between grade and Gleason score for each patient was investigated. According to Gleason scores, of our cases, 2 (5%) were grade I, 12 (30%) were grade II, 7 (18%) were grade III, 11 (27%) were grade IV and 8 (20%) were grade V. The p53 positivity was not observed in any of the grade I and grade II cases, but positive staining was determined in one out of grade III, two out of grade IV and three out of grade V cases. Average of PCNA index of grade I, grade II, grade III, grade IV and grade V cases was 1.310.5, 2.1±1.1, 4.7±2.3, 6.5±2.5, and 7.3±3.8 respectively, and average of the cases was 4.4±2.0. There was a significant correlation between grade and Gleason score with p53 and PCNA (p

Özet

Bu çalışmada Dicle Üniversitesi Tıp Fakültesi Patoloji Anabilim Dalı'nda 1996-1998 yılları arasında prostat kanseri tanısı alan 40 olgu incelendi. Olgulara ait kesitler p53 ve PCNA ile boyanarak grade ve Gleason skoru arasındaki ilişki araştırıldı. Gleason'a göre olgularımızın 2'si grade I(%5), 12'si grade II(%30), 7'si grade III(%18), II'i grade IV(%27) ve 8'i grade V(%20) idi. Grade I ve grade II olgularımızda p53 ile pozitiflik izlenmezken, grade III olgularımızın I'inde ve grade IV olgularımızın 2'sinde, grade V olgularımızdan ise 3'ünde pozitif boyanma saptandı. PCNA ile grade I olguların ortalama PCNA indeksi 1.310.5, grade II olguların 2.1±1.1, grade III olguların 4.7±2.3, grade IV olguların 6.5±2.5, grade V olguların 7.3±3.8 ve genel ortalama 4.4±2.0 idi. Grade ve Gleason skorları ile p53 ve PCNA arasında anlamlı bir ilişki vardı (p

🔖

Cite This Article

ŞAHİN, H., KILINÇ, N., YILMAZ, F., ARSLAN, A., UZUNLAR, A. K., YALDIZ, M. (2022). The relation between P53 and proliferating cell nuclear antigen (PCNA) expression with histological grade in the prostate adenocarcinoma. Anadolu Tıp Dergisi, Cilt: 2 - Sayı: 2, 101–106. https://ajindex.com/articles/648490

References (16)

  1. Baykal M, Çulha M, Demirbağ N ve ark. Prostat adenokarsinomunda ve benign prostat hiperplazisinde,hücre proliferasyonunun belirlenmesinde, proliferating cell nuclear antigen (PCNA) değişik evre ve derecelendirmedeki sonuçların karşılaştırılması.Türk Üroloji Dergisi 1997;23:248
  2. Celis JE, Celis A. Cell cycle dependent variations in the distribution of the protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci USA, 1985;82: 3262
  3. Deb S, Jackson CT, Subler MA et al. Modulation of cellular and viral promoters by mutant human p53 proteins was found in tumor cells. J Virol 1994;66:6164
  4. Fontanini G, Macchiarini P, Pepe S et al. The expression of proliferating cell nuclear antigen in paraffin sections of periferal, node negative,NSCLC. Cancer 1992;70:1520
  5. Gleason DF. Classification of prostatic carcinomas. Cancer Chemother Rep 1966;50:125
  6. Greenblatt MS, Bennett WP, Hollstein M et al.Mutations in the p53 tumor suppressor gene:Clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855
  7. Hall PA, Levinson DA, Woods AL et al. Proliferating cell nuclear antigene (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with the evidence of deregulated expression in some neoplasms. J Pathol 1990;162:285
  8. Hollstein M, Sidransky D, Vogelstein B et al. p53 mutations in human cancers. Science 1991;253:49
  9. Igawa M, Urakami S, Shiina H et al. Immunohistochemical evaluation of proliferating cell nuclear antigen, prostate-specific antigen and _____x 1-antichymotrypsin in human prostate cancer. Br J Urol 1996;77:107
  10. Iggo R, Gatter K, Bartek J et al. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 1990:335:675
  11. Lane DP, Crawford LV. T antigen is bound to a host protein in SV40 transformed cells. Nature 1979;278:261
  12. Levine AJ. The tumor supressor genes. Annu Rev Biochem 1993;62:623
  13. Mathews MB, Bernstei RM, Franza BR, Garrels JL. Identify of the proliferating cell nuclear antigen and cyclin. Nature 1984;33:374
  14. Mellon K, Thompson S, Marsh C et al. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malign prostate. J Urol 1992:147:496
  15. Mercer WE, Shields MT, Lin D et al. Growth suppression induced by wild type p53 protein is accompanied by selective down regulation of proliferating cell nuclear antigen expression. Proc Natl Acad Sci USA 1991:88:1958
  16. Mostofi FK, Sobin LH,